Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

KHK-IN-1

Inquiry
Cat. No.: OB0425LY-093
Synonyms: 1303469-70-6; 8-N-(Cyclopropylmethyl)-4-N-(2-methylsulfanylphenyl)-2-piperazin-1-ylpyrimido[5,4-d]pyrimidine-4,8-diamine; N8-(Cyclopropylmethyl)-N4-[2-(methylthio)phenyl]-2-(1-piperazinyl)-pyrimido[5,4-d]pyrimidine-4,8-diamine
Size: 50 mg; 100 mg; 250 mg
CAS No.: 1303469-70-6
Compound CID: 53348216
KHK-IN-1

Specification

Description: KHK-IN-1 is a small molecule compound that inhibits citrate kinase (KHK) and has important implications for metabolic diseases.
Formula Weight: 422.55
Applications: KHK-IN-1 can be used to study drug development for metabolic syndrome, diabetes-related diseases and obesity-related conditions.
Storage: Storage at -20°C.
Formula: C21H26N8S
Appearance: Solid
Purity: ≥95%
Pathway: Metabolic enzyme/Protease
Target: Ketohexokinase

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.